Visual Coronary and Aortic Calcium Scoring on Chest Computed Tomography Predict Mortality in Patients With Low-Density Lipoprotein-Cholesterol ≥190 mg/dL

被引:15
|
作者
Castagna, Francesco [1 ,2 ]
Miles, Jeremy [1 ]
Arce, Javier [1 ]
Leiderman, Ephraim [1 ]
Neshiwat, Patrick [1 ]
Ippolito, Paul [1 ]
Friedmann, Patricia [3 ,4 ]
Schenone, Aldo [1 ,2 ]
Zhang, Lili [1 ,2 ]
Rodriguez, Carlos J. [1 ,2 ]
Blaha, Michael J. [1 ,5 ]
Levsky, Jeffrey M. [6 ]
Garcia, Mario J. [2 ,6 ]
Slipczuk, Leandro [1 ,2 ]
机构
[1] Montefiore Med Ctr, Cardiol Div, 111 E 210th, Bronx, NY 10467 USA
[2] Albert Einstein Coll Med, Bronx, NY 10467 USA
[3] Albert Einstein Coll Med, Dept Surg, Bronx, NY 10467 USA
[4] Albert Einstein Coll Med, Dept Cardiothorac & Vasc Surg, Bronx, NY 10467 USA
[5] Johns Hopkins Ciccarone Ctr Prevent Heart Dis, Baltimore, MD USA
[6] Montefiore Med Ctr, Radiol Dept, 111 E 210th St, Bronx, NY 10467 USA
基金
美国国家卫生研究院;
关键词
calcium; coronary artery; risk factor; thoracic artery calcification; tomography; FAMILIAL HYPERCHOLESTEROLEMIA; CT SCANS; PROGNOSTIC VALUE; RISK; ATHEROSCLEROSIS; CALCIFICATION; SOCIETY; EVENTS;
D O I
10.1161/CIRCIMAGING.122.014135
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Current guidelines recommend coronary artery calcium (CAC) scoring for stratification of atherosclerotic cardiovascular disease risk only in patients with borderline to intermediate risk score by the pooled cohort equation with low-density lipoprotein-cholesterol (LDL-C) of 70 to 190 mg/dL. It remains unknown if CAC or thoracic aorta calcification (TAC), detected on routine chest computed tomography, can provide further risk stratification in patients with LDL-C >= 190 mg/dL. Methods: From a multisite medical center, we retrospectively identified all patients from March 2005 to June 2021 age >= 40 years, without established atherosclerotic cardiovascular disease and LDL-C >= 190 mg/dL who had non-gated non-contrast chest computed tomography within 3 years of LDL-C measurement. Ordinal CAC and TAC scores were measured by visual inspection. Kaplan-Meier curves and multivariable Cox-regression models were built to ascertain the association of CAC and TAC scores with all-cause mortality. Results: We included 811 patients with median age 59 (53-68) years, 262 (32.3%) were male, and LDL-C median level was 203 (194-217) mg/dL. Patients were followed for 6.2 (3.29-9.81) years, and 109 (13.4%) died. Overall, 376 (46.4%) of patients had CAC=0 and 226 (27.9%) had TAC=0. All-cause mortality increased with any CAC and moderate to severe TAC. In a multivariate model, patients with CAC had a significantly higher mortality compared with those without CAC: mild hazard ratio (HR), 1.71 (1.03-2.83), moderate HR, 2.12 (1.14-3.94), and severe HR, 3.49 (1.94-6.27). Patients with moderate TAC (HR, 2.34 [1.19-4.59]) and those with severe TAC (HR, 3.02 [1.36-6.74]) had higher mortality than those without TAC. Conclusions: In patients without history of atherosclerotic cardiovascular disease and LDL-C >= 190 mg/dL, the presence and severity of CAC and TAC are independently associated with all-cause mortality.
引用
收藏
页数:10
相关论文
共 23 条
  • [1] Total cholesterol/high-density lipoprotein cholesterol and low-density lipoprotein cholesterol/high-density lipoprotein cholesterol as predictors of coronary artery calcification assessed by multidetector computed tomography coronary angiography
    Seaoud, Elshaimaa Aly M. Elsadek
    Amin, Mohamed Ibrahim
    Abdelbasit, Mohamed Salah
    ARYA ATHEROSCLEROSIS, 2022, 18
  • [2] Relation of High-Density Lipoprotein Cholesterol to Mortality After Percutaneous Coronary Interventions in Patients With Low-Density Lipoprotein <70 mg/dl
    Kini, Annapoorna S.
    Muntner, Paul
    Moreno, Pedro R.
    Mann, Devin
    Krishnan, Prakash
    Kim, Michael C.
    Rafael, Oana C.
    Farkouh, Michael E.
    Sharma, Samin K.
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (03) : 350 - 354
  • [3] Cholesterol Efflux and Metabolic Abnormalities Associated With Low High-Density-Lipoprotein-Cholesterol and High Triglycerides in Statin-Treated Coronary Men With Low-Density Lipoprotein-Cholesterol <70 mg/dl
    Posadas-Sanchez, Rosalinda
    Posadas-Romero, Carlos
    Mendoza-Perez, Enrique
    Caracas-Portilla, Nacil Aureo
    Cardoso-Saldana, Guillermo
    Medina-Urrutia, Aida
    Jorge-Galarza, Esteban
    Juarez-Rojas, Juan Gabriel
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (05) : 636 - 641
  • [4] Sustained low-density lipoprotein-cholesterol <70 mg/dl is associated with improved cardiovascular outcomes in the clinical setting
    Sanchez-Bacaicoa, Carmen
    Galan, Javier
    Guijarro, Carlos
    Rico-Martin, Sergio
    Monreal, Manuel
    Calderon-Garcia, Julian F.
    Aguilar-Cortes, Eduardo
    Sanchez Munoz-Torrero, Juan F.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2022, 52 (05)
  • [5] Frequency of Statin Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dl from the Veterans Affairs Health System
    Rodriguez, Fatima
    Knowles, Joshua W.
    Maron, David J.
    Virani, Salim S.
    Heidenreich, Paul A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 122 (05) : 756 - 761
  • [6] Obstructive sleep apnea is associated with visit-to-visit variability in low-density lipoprotein-cholesterol in patients with coronary artery disease
    Ng, Gavin
    Boey, Elaine
    Frampton, Chris
    Richards, Arthur Mark
    Yeo, Tiong-Cheng
    Lee, Chi-Hang
    SLEEP AND BREATHING, 2017, 21 (02) : 271 - 278
  • [7] Relationship of High-Density Lipoprotein Cholesterol With Periprocedural Myocardial Injury Following Elective Percutaneous Coronary Intervention in Patients With Low-Density Lipoprotein Cholesterol Below 70 mg/dL
    Li, Xiao-Lin
    Guo, Yuan-Lin
    Zhu, Cheng-Gang
    Xu, Rui-Xia
    Qing, Ping
    Wu, Na-Qiong
    Jiang, Li-Xin
    Xu, Bo
    Gao, Run-Lin
    Li, Jian-Jun
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2015, 4 (01): : e001412
  • [8] Use of Moderate-Intensity Statins for Low-Density Lipoprotein Cholesterol Level above 190mg/dL at Baseline in Koreans
    Kim, Hun-Sung
    Lee, Hyeseon
    Lee, Sue Hyun
    Jeong, Yoo Jin
    Kim, Tong Min
    Yang, So Jung
    Baik, Sun Jung
    Kim, Hyunah
    Lee, Seung-Hwan
    Cho, Jae Hyoung
    Choi, In-Young
    Yoon, Kun-Ho
    Kim, Ju Han
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2017, 121 (04) : 272 - 278
  • [9] Efficacy, safety and clinical outcome associated with statin use for primary prevention in Korean patients with low-density lipoprotein cholesterol level ≥ 190 mg/dL: A retrospective cohort study
    Kim, Hack-Lyoung
    Lim, Woo-Hyun
    Seo, Jae-Bin
    Zo, Joo-Hee
    Kim, Myung-A
    Kim, Sang-Hyun
    PLOS ONE, 2023, 18 (06):
  • [10] Benefits of Statin Therapy in Patients With Acute Myocardial Infarction With Serum Low-Density Lipoprotein Cholesterol ≤ 50 mg/dl
    Piao, Zhe Hao
    Jin, Li
    Kim, Ju Han
    Ahn, Youngkeun
    Kim, Young Jo
    Cho, Myeong Chan
    Kim, Chong Jin
    Kim, Hyo Soo
    Liu, Bin
    Jeong, Myung Ho
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (02) : 174 - 180